- •Practicing Obstetricians use both risk-based and universal screening for Hepatitis C virus.
- •Professional guidance from OB/GYN, public health and infectious diseases societies are important factors is an important factor influencing what strategy they choose.
- •Now that universal screening for Hepatitis C is recommended for all adults, consensus guidelines should be created to endorse universal screening during pregnancy as an important step towards Hepatitis C eradication.
Hepatitis C virus (HCV) cases have increased in the past decade, with many cases in pregnant patients. However, recommendations for HCV screening during pregnancy vary by professional organization.
Prenatal care providers were surveyed via e-mail about factors affecting choice of HCV screening.
A total of 86 completed surveys were received. Providers using risk-based screening valued guidance from obstetrics and gynecology societies and risk for vertical transmission. Providers using universal screening valued availability of curative treatment in addition to guidance from the Centers for Disease Control and Prevention/infectious diseases societies and obstetrics and gynecology societies.
The results highlight the need for consensus guidelines on HCV screening as a part of prenatal care.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinical Therapeutics
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Hepatitis C in pregnancy in the era of direct-acting antiviral treatment: potential benefits of universal screening and antepartum therapy.Clin Obstet Gynecol. 2018; 61: 146-156
- Universal screening of pregnant women for hepatitis C: the time is now.Clin Infect Dis. 2018; 67: 1493-1497
- Vital signs: newly reported acute and chronic hepatitis C cases—United States, 2009-2018.MMWR Morb Mortal Wkly Rep. 2020; 69: 399-404
- Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014.Ann Intern Med. 2017; 166: 775-782
- HCV in pregnancy.2018 ([updated August 27, 2020]. Available from:)https://www.hcvguidelines.org/unique-populations/pregnancyDate accessed: May 17, 2020
- CDC recommendations for hepatitis C screening among adults—United States, 2020.MMWR Recomm Rep. 2020; 69: 1-17
- Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement.JAMA. 2020; 323: 970-975
- Hepatitis C in pregnancy: screening, treatment, and management.Am J Obstet Gynecol. 2017; 217: B2-B12
- New antiviral agents for treatment of hepatitis C.Clin Obstet Gynecol. 2019; 62: 823-834
- Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study.Lancet Microbe. 2020; 1: e200-e208
- Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care.Obstet Gynecol. 2019; 133: 289-300
- Healthy People 2030—Overview and Objectives: Infectious Diseases.DHHS, Bethesda, Md2020
Published online: February 05, 2021
Accepted: January 14, 2021
© 2021 Elsevier Inc.